[go: up one dir, main page]

UA92604C2 - Композиция стансопорфина с физиологической осмотической концентрацией и ее применение - Google Patents

Композиция стансопорфина с физиологической осмотической концентрацией и ее применение

Info

Publication number
UA92604C2
UA92604C2 UAA200712058A UAA200712058A UA92604C2 UA 92604 C2 UA92604 C2 UA 92604C2 UA A200712058 A UAA200712058 A UA A200712058A UA A200712058 A UAA200712058 A UA A200712058A UA 92604 C2 UA92604 C2 UA 92604C2
Authority
UA
Ukraine
Prior art keywords
stannsoporfin
composition
physiological osmolarity
pharmaceutical compositions
methods
Prior art date
Application number
UAA200712058A
Other languages
English (en)
Ukrainian (uk)
Inventor
Филип К. Ленг
Джордж С. Драммонд
Original Assignee
Инфакеар Фармасьютикал Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Инфакеар Фармасьютикал Корпорейшн filed Critical Инфакеар Фармасьютикал Корпорейшн
Publication of UA92604C2 publication Critical patent/UA92604C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретение раскрывает фармацевтические композиции, которые содержат стансопорфин, а также способы лечения гипербилирубинемии с их помощью.
UAA200712058A 2005-04-01 2006-03-31 Композиция стансопорфина с физиологической осмотической концентрацией и ее применение UA92604C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/096,359 US20060222668A1 (en) 2005-04-01 2005-04-01 Stannsoporfin compositions, drug products and methods of manufacture

Publications (1)

Publication Number Publication Date
UA92604C2 true UA92604C2 (ru) 2010-11-25

Family

ID=37070775

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200712058A UA92604C2 (ru) 2005-04-01 2006-03-31 Композиция стансопорфина с физиологической осмотической концентрацией и ее применение

Country Status (11)

Country Link
US (3) US20060222668A1 (ru)
EP (1) EP2301548A1 (ru)
JP (1) JP2008534618A (ru)
CN (1) CN101160053A (ru)
BR (1) BRPI0609794A2 (ru)
EA (1) EA013597B1 (ru)
IL (1) IL186337A0 (ru)
MX (1) MX2007012166A (ru)
NZ (1) NZ562158A (ru)
UA (1) UA92604C2 (ru)
ZA (1) ZA200708892B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7375216B2 (en) * 2002-06-04 2008-05-20 Infacare Pharmaceutical Corporation Preparation of metal mesoporphyrin compounds
US20060222668A1 (en) * 2005-04-01 2006-10-05 Wellspring Pharmaceutical Corporation Stannsoporfin compositions, drug products and methods of manufacture
US8142781B2 (en) * 2005-10-07 2012-03-27 Armagen Technologies, Inc. Fusion proteins for blood-brain barrier delivery
JP2010505854A (ja) * 2006-10-04 2010-02-25 インファケア ファーマスーティカル，コーポレイション 低投与量のスタンソポルフィンを用いる幼児の高ビリルビン血症の治療
ATE524187T1 (de) 2006-10-04 2011-09-15 Infacare Pharmaceutical Corp Herstellung grosser mengen von hochreinem stannsoporfin
DK2691398T3 (en) 2011-03-30 2017-01-16 Infacare Pharmaceutical Corp Methods for synthesizing metal mesoporphyrins

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684637A (en) * 1981-07-15 1987-08-04 The Rockefeller University Method of decreasing rate of heme metabolism
US4708964A (en) * 1984-02-09 1987-11-24 Chemex Pharmaceuticals Lipoxygenase inhibitors
US4619923A (en) * 1985-01-14 1986-10-28 The Rockefeller University Metal protoporphyrins in the control of tryptophan metabolism
US4657902A (en) * 1985-03-25 1987-04-14 The Rockefeller University Therapeutic use of tin mesoporphyrin
US4692440A (en) * 1985-03-25 1987-09-08 The Rockefeller University Therapeutic use of tin mesoporphyrin
US4692439A (en) * 1986-06-20 1987-09-08 The Rockefeller University Therapeutic use of tin diiododeuteroporphyrin
US4668670A (en) * 1986-06-20 1987-05-26 The Rockefeller University Tin diiododeuteroporphyrin and therapeutic use thereof
US4861876A (en) * 1986-11-26 1989-08-29 Wayne State University Hematoporphyrin derivative and method of preparation and purification
US4782049A (en) * 1986-12-08 1988-11-01 The Rockefeller University Tin protoporphyrin and tin mesoporphyrin in the treatment of psoriasis
US4900871A (en) * 1987-01-02 1990-02-13 Sun Refining And Marketing Company Hydrocarbon oxidations catalyzed by iron coordination complexes containing a halogenated ligand
US5990363A (en) * 1987-01-02 1999-11-23 Sun Company, Inc. Method for oxidizing alkanes using novel porphyrins synthesized from dipyrromethanes and aldehydes
US5081115A (en) * 1987-10-15 1992-01-14 The Board Of Trustees Of The Leland Stanford Junior University Method to prevent neonatal jaundice with metalloporphyrin compositions
US4831024A (en) * 1987-10-15 1989-05-16 The Board Of Trustees Of The Leland Stanford Junior University Method to prevent neonatal jaundice
DE3827940A1 (de) * 1988-08-13 1990-03-01 Schering Ag 13,17-propionsaeure- und propionsaeurederivat- substituierte porphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US4861676A (en) * 1988-08-29 1989-08-29 E. I. Du Pont De Nemours And Company Improved coextrudable adhesive and products therefrom
US5162313A (en) * 1989-03-16 1992-11-10 The Rockefeller University Control of heme and iron concentrations in body tissues
US5223494A (en) * 1989-09-25 1993-06-29 The Rockefeller University Orally administered porphyrins to control intestinal iron absorption
US5062775A (en) * 1989-09-29 1991-11-05 Rocky Mountain Research, Inc. Roller pump in an extra corporeal support system
US5010073A (en) * 1989-10-05 1991-04-23 The Rockefeller University Use of liposomes as carriers for metalloporphyrins
US5192757A (en) * 1990-12-20 1993-03-09 Glaxo Inc. Cobalt porphyrins
US5371199B1 (en) * 1992-08-14 1995-12-26 Univ Pennsylvania Substituted porphyrins porphyrin-containing polymers and synthetic methods therefor
US5817830A (en) * 1992-08-14 1998-10-06 Trustees Of The University Of Pennsylvania Pyrrolic compounds
US5493017A (en) * 1992-08-14 1996-02-20 The Trustees Of The University Of Pennsylvania Ring-metalated porphyrins
CA2130853A1 (en) * 1994-08-25 1996-02-26 Svetlana Kudrevich Process for the syntheses of monosulphonated phthalocyanines, naphthobenzoporphyrazines and porphyrins via a modified meerwein reaction
US6066333A (en) * 1994-09-22 2000-05-23 William Harvey Research Limited Pharmaceutical control of inflammation
US5912341A (en) * 1995-03-14 1999-06-15 Hoffman/Barrett, L.L.C. Heteroatom-functionalized porphyrazines and multimetallic complexes and polymers derived therefrom
US5929064A (en) * 1995-08-02 1999-07-27 Warner-Lambert Company Amino acid complexes of cobalt (III) mesoporphyrin IX and cobalt (III) protoporphyrin IX
US5883246A (en) * 1996-03-07 1999-03-16 Qlt Phototherapeutics, Inc. Synthesis of polypyrrolic macrocycles from meso-substituted tripyrrane compounds
US6004530A (en) * 1996-06-04 1999-12-21 Roche Diagnostics Gmbh Use of metallo-porphyrin conjugates for the detection of biological substances
GB9616353D0 (en) * 1996-08-03 1996-09-11 Secr Defence Metallo-porphyrins
US6124452A (en) * 1997-12-19 2000-09-26 University Of Nebraska-Lincoln Octafluoro-meso-tetraarylporphyrins and methods for making these compounds
DE19706490C1 (de) * 1997-02-19 1998-09-17 Deutsches Krebsforsch Verfahren zur Herstellung von Säureamiden und zur Metallierung von Verbindungen und Verwendung der nach den Verfahren hergestellten Verbindungen
US5886173A (en) * 1997-07-30 1999-03-23 Pharmacyclics, Inc. Metallation of macrocycles with 2,4-dicarbonyl-metal complexes
US6194566B1 (en) * 1997-12-02 2001-02-27 Schering Aktiengesellschaft Process for the production of metalloporphyrin-metal complex conjugates
JP3673888B2 (ja) * 1998-03-09 2005-07-20 独立行政法人科学技術振興機構 ポルフィリン類金属錯体の製造方法
DE19831217A1 (de) * 1998-07-03 2000-01-05 Schering Ag Neue Porphyrinderivate, diese enthaltende pharmazeutische Mittel und ihre Verwendung in der photodynamischen Therapie und MRI-Diagnostik
US5973141A (en) * 1998-11-27 1999-10-26 Miravant Pharmaceuticals, Inc. Method for the demethoxycarbonylation of porphyrinic compounds such as pheophorbides
US6462192B2 (en) * 2001-01-23 2002-10-08 Miravant Pharmaceuticals, Inc. Processes for large scale production of tetrapyrroles
WO2002096417A1 (en) * 2001-05-31 2002-12-05 Miravant Pharmaceuticals, Inc. Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and mri diagnosis
US7375216B2 (en) * 2002-06-04 2008-05-20 Infacare Pharmaceutical Corporation Preparation of metal mesoporphyrin compounds
WO2003101999A2 (en) * 2002-06-04 2003-12-11 Wellspring Pharmaceutical Corporation Preparation of metal mesoporphyrin halide compounds
US20040097481A1 (en) * 2002-11-20 2004-05-20 Benjamin Levinson Water-soluble mesoporphyrin compounds and methods of preparation
DE602004019761D1 (de) * 2003-01-08 2009-04-16 Novartis Vaccines & Diagnostic Stabilisierte wässrige zusammensetzungen mit gewebefaktorinhibitor (tfpi) oder gewebefaktorinhibitor-variante
US20060222668A1 (en) * 2005-04-01 2006-10-05 Wellspring Pharmaceutical Corporation Stannsoporfin compositions, drug products and methods of manufacture
ATE524187T1 (de) * 2006-10-04 2011-09-15 Infacare Pharmaceutical Corp Herstellung grosser mengen von hochreinem stannsoporfin
JP2010505854A (ja) * 2006-10-04 2010-02-25 インファケア ファーマスーティカル，コーポレイション 低投与量のスタンソポルフィンを用いる幼児の高ビリルビン血症の治療

Also Published As

Publication number Publication date
BRPI0609794A2 (pt) 2010-04-27
US20060222669A1 (en) 2006-10-05
EA200702136A1 (ru) 2008-04-28
CN101160053A (zh) 2008-04-09
US20080261939A1 (en) 2008-10-23
NZ562158A (en) 2011-04-29
ZA200708892B (en) 2008-06-25
MX2007012166A (es) 2007-12-10
US20060222668A1 (en) 2006-10-05
EP2301548A1 (en) 2011-03-30
IL186337A0 (en) 2008-01-20
EA013597B1 (ru) 2010-06-30
JP2008534618A (ja) 2008-08-28

Similar Documents

Publication Publication Date Title
MX2009000285A (es) Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
MX2007010996A (es) Nuevas composiciones de liposomas.
EP2217596B8 (en) Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119
DE602007010764D1 (en) Benzamidglucokinaseaktivatoren
GEP20125565B (en) Lactam compounds and their pharmaceutical use
UA104988C2 (ru) Производные пирониндола и способ их получения
SG166093A1 (en) Inhibitors of brutonæs tyrosine kinase
IL193678A (en) Derivatives of pyrazolyl-theophane, pharmaceuticals containing them and their use in the preparation of drugs to improve cognitive activity
MX2007008790A (es) Pirazolo piridinas sustituidas, composiciones que las contienen, metodo de produccion de las mismas, y su uso.
MY143795A (en) Tetrahydropyridoindole derivatives
NZ588913A (en) Liver cancer drug
JO2721B1 (en) Derivatives of artemisia plant and its preparations and therapeutic applications
TW200716628A (en) Novel compounds
MY148723A (en) Use of pinolenic acid for the treatment of obesity
TW200738627A (en) Trialkylsilyl-indoles
WO2006138608A3 (en) Pharmaceutical compositions and use thereof
TW200630128A (en) Active ingredient-containing silicone elastomers
EP1503748A4 (en) DRUGS TO REDUCE TAXAN-INDUCED NEUROTOXICITY
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
MX2009001433A (es) Nucleosidos para suprimir o reducir el desarrollo de resistencia en terapia citostatica.
TW200745132A (en) Novel, acyclically substituted furopyrimidine derivatives and use thereof
UA92604C2 (ru) Композиция стансопорфина с физиологической осмотической концентрацией и ее применение
IL194353A0 (en) Lysobactin amides
WO2006133194A3 (en) Methods for treating viral infection with oral or injectible drug solution
GB2443377A (en) Anti-malarial composition comprising artesunate and lumefantrine